A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis

Background and purpose: Recently, the use of immunotoxins for targeted cancer therapy has been proposed, to find new anticancer drugs with high efficacy on tumor cells with minimal side effects on normal cells. we designed and compared several arazyme (AraA)-based fusion proteins with different liga...

Full description

Bibliographic Details
Main Authors: Rezvan Mehrab, Hamid Sedighian, Fattah Sotoodehnejadnematalahi, Raheleh Halabian, Abbas Ali Imani Fooladi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=2;spage=159;epage=176;aulast=Mehrab